HIV Citation List: February 4 - February 17, 2009

Pubmed citations:

1) Antiviral drug discovery: Ten more compounds, and ten more stories (part B). De Clercq E. Med Res Rev. 2009 Feb 13. [Epub ahead of print]

PMID: 19219846

2) The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34+-derived macrophages by blocking HIV-1 DNA integration. Porcellini S, Alberici L, Gubinelli F, Lupo R, Olgiati C, Rizzardi GP, Bovolenta C. Blood. 2009 Feb 11. [Epub ahead of print]

PMID: 19211937

3) Pharmaceutical approaches to eradication of persistent HIV infection. Bowman MC, Archin NM, Margolis DM. Expert Rev Mol Med. 2009 Feb 11;11:e6.

PMID: 19208267

4) Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action. Zhu WL, Shin SY. J Pept Sci. 2009 Feb 10. [Epub ahead of print]

PMID: 19206074

5) Additivity in the analysis and design of HIV protease inhibitors. Jorissen RN, Reddy GS, Ali A, Altman MD, Chellappan S, Anjum SG, Tidor B, Schiffer CA, Rana TM, Gilson MK. J Med Chem. 2009 Feb 12;52(3):737-54.

PMID: 19193159

6) 1-Amido-1-phenyl-3-piperidinylbutanes - CCR5 antagonists for the treatment of HIV. Part 1. Barber CG, Blakemore DC, Chiva JY, Eastwood RL, Middleton DS, Paradowski KA. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1075-1079. Epub 2009 Jan 10.

PMID: 19171484

7) The design and discovery of novel amide CCR5 antagonists. Pryde DC, Corless M, Fenwick DR, Mason HJ, Stammen BC, Stephenson PT, Ellis D, Bachelor D, Gordon D, Barber CG, Wood A, Middleton DS, Blakemore DC, Parsons GC, Eastwood R, Platts MY, Statham K, Paradowski KA, Burt C, Klute W. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1084-1088. Epub 2009 Jan 10.

PMID: 19167884

8) Tricyclic HIV integrase inhibitors: VI. SAR studies of 'benzyl flipped' C3-substituted pyrroloquinolines. Metobo S, Mish M, Jin H, Jabri S, Lansdown R, Chen X, Tsiang M, Wright M, Kim CU. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1187-1190. Epub 2008 Dec 25.

PMID: 19167883

9) Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants. Radi M, Maga G, Alongi M, Angeli L, Samuele A, Zanoli S, Bellucci L, Tafi A, Casaluce G, Giorgi G, Armand-Ugon M, Gonzalez E, Esté JA, Baltzinger M, Bec G, Dumas P, Ennifar E, Botta M. J Med Chem. 2009 Feb 12;52(3):840-51.

PMID: 19140683

10) Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity. Feng XQ, Liang YH, Zeng ZS, Chen FE, Balzarini J, Pannecouque C, De Clercq E. ChemMedChem. 2009 Feb 13;4(2):219-224.

PMID: 19090525

11) Interactions of HIV-1 Inhibitory Peptide T20 with the gp41 N-HR Coiled Coil. Champagne K, Shishido A, Root MJ. J Biol Chem. 2009 Feb 6;284(6):3619-27. Epub 2008 Dec 10.

PMID: 19073602

ISI Web of Science citations:

12) The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3 ',3 '-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain. DaFonseca S, Coric P, Gay B, Hong SS, Bouaziz S, Boulanger P. VIROLOGY JOURNAL. 2008 Dec 23;5:162.

13) Synthesis and antimicrobial evaluation of 6-azauracil non-nucleosides. El-Brollosy NR. MONATSHEFTE FUR CHEMIE. 2008 DEC;139(12):1483-1493.

14) In search of small molecules blocking interactions between HIV proteins and intracellular cofactors. Busschots K, De Rijck J, Christ F, Debyser Z. MOLECULAR BIOSYSTEMS. 2009;5(1):21-31.

15) DESIGN OF HYBRID INHIBITORS TO HIV-1 PROTEASE. Zhang DW, Huang PL, Lee-Huang S, Zhang JZH. JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY. 2008 AUG;7(4):484-503.

16) Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex. Samuele A, Kataropoulou A, Viola M, Zanoli S, La Regina G, Piscitelli F, Silvestri R, Maga G. ANTIVIRAL RESEARCH. 2009 JAN;81(1):47-55.

17) Characterization of Cyclodextrin Inclusion Complexes of the Anti-HIV Non-Nucleoside Reverse Transcriptase Inhibitor UC781. Yang HT, Parniak MA, Isaacs CE, Hillier SL, Rohan LC. AAPS JOURNAL. 2008 DEC;10(4):606-613.

18) Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites. Berchanski A, Lapidot A. JOURNAL OD MOLECULAR MODELING. 2009 MAR;15(3):281-294.

Patent citations:

19) Short Synthesis and Antiviral Activity of Acyclic Phosphonic Acid Nucleoside Analogues. Liu, Lian Jin; Yoo, Jin Cheol; Hong, Joon Hee. College of Pharmacy, Chosun University, Kwangju, S. Korea. Nucleosides, Nucleotides & Nucleic Acids (2009), 28(2), 150-164. Publisher: Taylor & Francis, Inc., CODEN: NNNAFY ISSN: 1525-7770. Journal written in English. AN 2009:188831 CAPLUS

20) Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties. Sweeney, Zachary K.; Kennedy-Smith, Joshua J.; Wu, Jeffrey; Arora, Nidhi; Billedeau, J. Roland; Davidson, James P.; Fretland, Jennifer; Hang, Julie Q.; Heilek, Gabrielle M.; Harris, Seth F.; Hirschfeld, Donald; Inbar, Petra; Javanbakht, Hassan; Jernelius, Jesper A.; Jin, Qingwu; Li, Yu; Liang, Weiling; Roetz, Ralf; Sarma, Keshab; Smith, Mark; Stefanidis, Dimitrio; Su, Guoping; Suh, Judy M.; Villasenor, Armando G.; Welch, Michael; Zhang, Fang-Jie; Klumpp, Klaus. Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA, USA. ChemMedChem (2009), 4(1), 88-99. Publisher: Wiley-VCH Verlag GmbH & Co. KGaA, CODEN: CHEMGX ISSN: 1860-7179. Journal written in English. AN 2009:166475 CAPLUS

21) Introducing metallocene into a triazole peptide conjugate reduces its off-rate and enhances its affinity and antiviral potency for HIV-1 gp120. Gopi Hosahudya; Cocklin Simon; Pirrone Vanessa; McFadden Karyn; Tuzer Ferit; Zentner Isaac; Ajith Sandya; Baxter Sabine; Jawanda Navneet; Krebs Fred C; Chaiken Irwin M Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102, USA Journal of molecular recognition : JMR (2009), 22(2), 169-74. Journal code: 9004580. ISSN:0952-3499. Journal; Article; (JOURNAL ARTICLE) written in English. PubMed ID 18498083 AN 2009127898 In-process for MEDLINE (Copyright (C) 2009 U.S. National Library of Medicine on SciFinder (R))

22) Preparation of piperidine derivatives as agonists of chemokine receptor activity. Huck, Jacques; Ooms, Frederic; Tyrchan, Christian; Hoveyda, Hamid R. (Euroscreen S.A., Belg.). PCT Int. Appl. (2009), 199pp. CODEN: PIXXD2 WO 2009010478 A2 20090122 Application: WO 2008-EP59137 20080711.

23) Preparation of piperidine-4-acetic acid derivatives as chemokine receptor agonists. Huck, Jacques; Ooms, Frederic; Parcq, Julien; Regereau, Yannick; Hoveyda, Hamid R.; Dutheuil, Guillaume. (Euroscreen S.A., Belg.). PCT Int. Appl. (2009), 224pp. CODEN: PIXXD2 WO 2009010477 A1 20090122 Application: WO 2008-EP59136 20080711.

24) Preparation of novel therapeutic compounds containing heterocylic carboxamide cores for use as kinase inhibitors. Breinlinger, Eric C.; Cusack, Kevin P.; Hobson, Adrian D.; Li, Bin; Gordon, Thomas D.; Stoffel, Robert H.; Wallace, Grier A.; Gronsgaard, Pintipa; Wang, Lu. (Abbott Laboratories, USA). PCT Int. Appl. (2009), 224pp. Application: WO 2008-US8645 20080715.

25) Preparation of diphenylaminoethylpiperidinecarboxylic acid benzylamide derivatives and analogs as CCR5 agonists. Huck, Jacques; Ooms, Frederic; Parcq, Julien. (Euroscreen S.A., Belg.). PCT Int. Appl. (2009), 184pp. CODEN: PIXXD2 WO 2009010480 A1 20090122 Application: WO 2008-EP59139 20080711.

26) Preparation of heterocyclic methylene piperidine derivatives as therapeutic chemokine receptor modulators. Huck, Jacques; Ooms, Frederic; Regereau, Yannick. (Euroscreen S.A., Belg.). PCT Int. Appl. (2009), 167pp. CODEN: PIXXD2 WO 2009010479 A2 20090122 Application: WO 2008-EP59138 20080711.

27) Antiviral properties of zosteric acid and related molecules. Michael, Scott F.; Isern, Sharon; Costin, Joshua. (Florida Gulf Coast University, USA). PCT Int. Appl. (2009), 36pp. Application: WO 2008-US69808 20080711.

28) Apricitabine - a novel nucleoside reverse transcriptase inhibitor for the treatment of HIV infection that is refractory to existing drugs. Cox, Susan; Southby, Justine. Avexa Ltd., Richmond, VA, USA. Expert Opinion on Investigational Drugs (2009), 18(2), 199-209. Publisher: Informa Healthcare, CODEN: EOIDER ISSN: 1354-3784. Journal written in English. AN 2009:74143 CAPLUS

29) Substituted nucleoside derivatives with antiviral and antimicrobial properties. Doncel, Gustavo F.; Parang, Keykavous; Agrawal, Hitesh Kumar. (Eastern Virginia Medical School, USA). PCT Int. Appl. (2009), 96pp. CODEN: PIXXD2 WO 2009009625 A2 20090115 Application: WO 2008-US69571 20080709.

30) Preparation of deuterium substituted pyrimidine derivatives as HIV integrase inhibitors. Harbeson, Scott L. (Concert Pharmaceuticals Inc., USA). PCT Int. Appl. (2009), 40pp. CODEN: PIXXD2 WO 2009009531 A2 20090115 Application: WO 2008-US69425 20080708.

31) Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile, its preparation and therapeutical uses thereof. Stokbroekx, Sigrid Carl Maria; Leys, Carina; Theunissen, Elisabeth Maria Helene Egide Ghislaine; Baert, Lieven Elvire Colette. (Tibotec Pharmaceuticals Ltd., Ire.). PCT Int. Appl. (2009), 35pp. Application: WO 2008-EP59054 20080711.

32) A CXC chemokine receptor 4 (CXCR4) antagonistic polypeptide. Forssmann, Wolf-Georg; Kirchhoff, Frank; Muench, Jan; Staendker, Ludger. (Pharis Biotec G.m.b.H., Germany). PCT Int. Appl. (2009), 55pp. CODEN: PIXXD2 WO 2009004054 A2 20090108. Application: WO 2008-EP58566 20080703.

33) Novel triazolopyridazine derivatives as kinase inhibitors and their preparation and use in the treatment of diseases. Calderwood, David J.; Bonafoux, Dominique F.; Burchat, Andrew; Ding, Ping; Frank, Kristine E.; Hoemann, Michael Z.; Mullen, Kelly D.; Davis, Heather M. (Abbott Laboratories, USA). PCT Int. Appl. (2009), 226pp. CODEN: PIXXD2 WO 2009005675 A1 20090108 Application: WO 2008-US7926 20080626.

34) Stereoisomers of tricyclodecan-9-yl-xanthogenate and their preparation and use in the treatment of viral diseases. Tomioka, Miyuki; Hasegawa, Ko. (Shogoo Pharmaceuticals A.-G., Switz.). PCT Int. Appl. (2009), 94pp. CODEN: PIXXD2 WO 2009003711 A2 20090108 Application: WO 2008-EP5460 20080703.

35) Preparation of pyrimidindiones as HIV reverse transcriptase inhibitors. Guo, Hongyan; Kim, Choung U.; Lee, Ill Young; Mitchell, Michael L.; Rhodes, Gerry; Son, Jong Chan; Xu, Lianhong. (Gilead Sciences, Inc., USA; Korean Research Institute of Chemical Technology). PCT Int. Appl. (2009), 466pp. CODEN: PIXXD2 WO 2009005674 A2 20090108 Application: WO 2008-US7925 20080626.

36) Preparation of pyrimidinediones as HIV reverse transcriptase inhibitors. He, Gong-Xin; Kim, Choung U.; Mitchell, Michael L.; Xu, Lianhong. (Gilead Sciences, Inc., USA). PCT Int. Appl. (2009), 145pp. CODEN: PIXXD2 WO 2009005693 A1 20090108 Application: WO 2008-US7970 20080626.

37) Novel azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) in antiviral therapy (HIV). Jorgensen, William L. (Yale University, USA). PCT Int. Appl. (2009), 68pp. CODEN: PIXXD2 WO 2009005811 A1 20090108 Application: WO 2008-US8214 20080702.